According to CoinMeta, as reported by Coin Bureau, the first US-deposited Injective ETF began trading on NASDAQ today, while Injective and Canary Capital had their opening bells rung at Times Square. The stock, denominated in $INJC, rose by 3% after its listing. This ETF allows investors to access INJ through brokerage accounts and to pledge a large portion of their holdings in Injective. Since November 3rd, $INJ has risen by nearly 26% driven by the listing news, despite a sharp sell-off in the overall crypto market.